Vantage Consulting Group Inc

Est. AUM

$19.72B

13F long equity, this entity only

Positions

Period

Dec 2025 (Q4)

SEC EDGAR

Dec 2025 (Q4)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	Babcock & Wilcox Enterprises Inc.	COM	$15.32B	2416200	77.68%	SOLE
2	ADC Therapeutics SA	COM	$2.41B	682998	12.23%	SOLE
3	Cibus, Inc.	COM	$1.99B	1143949	10.09%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.